Exousia Bio, Inc. Cash and Cash Equivalents
Exousia Bio, Inc. (LMMY) had Cash and Cash Equivalents of $1.32 thousand as of 2023-08-31, per its 10-Q filed 2023-10-11.
Discontinued
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2023-10-11
- 2023-08-31: Cash and Cash Equivalents, at Carrying Value $1.32K.
- 2023-05-31: Cash and Cash Equivalents, at Carrying Value $7.86K.
- 2023-02-28: Cash and Cash Equivalents, at Carrying Value $4.16K.
- 2022-05-31: Cash and Cash Equivalents, at Carrying Value $10.11K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2023-08-31 | $1.32K 10-Q · filed 2023-10-11 |
| 2023-05-31 | $7.86K 10-Q · filed 2023-10-11 |
| 2023-02-28 | $4.16K 10-Q · filed 2023-05-08 |
| 2022-05-31 | $10.11K 10-K · filed 2023-09-01 |